Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival

被引:61
作者
Donadon, Matteo [1 ,2 ]
Hudspeth, Kelly [3 ]
Cimino, Matteo [1 ,2 ]
Di Tommaso, Luca [4 ]
Preti, Max [3 ]
Tentorio, Paolo [3 ]
Roncalli, Massimo [4 ]
Mavilio, Domenico [3 ,5 ]
Torzilli, Guido [1 ,2 ]
机构
[1] Humanitas Univ, Dept Hepatobiliary & Gen Surg, Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Milan, Italy
[2] Humanitas Univ, Humanitas Clin & Res Ctr, Lab Hepatobiliary Surg, Milan, Italy
[3] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy
[4] Humanitas Univ, Dept Pathol, Humanitas Clin & Res Ctr, Milan, Italy
[5] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy
关键词
Colorectal liver metastases; Chemotherapy; Natural killer cells; Tcells; Immune response to colorectal liver metastases; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; HEPATIC RESECTION; NK CELLS; IMMUNE-RESPONSE; CANCER; CHEMOTHERAPY; LYMPHOCYTES; CARCINOMA; CETUXIMAB;
D O I
10.1007/s11605-017-3446-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Cancer heterogeneity and degree of intra-tumoral immune cells represent variables affecting overall survival (OS). The present study investigated the impact of natural killer (NK) and T cells infiltrating colorectal liver metastases (CLM) in patients undergoing hepatectomy after neoadjuvant chemotherapy. Methods The frequencies of intra-tumoral, marginal, and peritumoral CD3+ T and NKp46+ NK cells were determined for 121 patients. OS was assessed in relation to prognostic factors. Results At univariate analysis, several variables, including T and N of the primary tumor, metachronous CLM, radiological response, and higher density of intra-tumoral CD3+ T cell (>1%/mm(2)) and of NKp46+ NK cells (>1 cell/mm(2)), were associated with OS. Only increased frequencies of intra-tumoral CD3+ Tcells (p = 0.005) and NKp46+ NK cells (p = 0.004) correlated with OS at multivariate analysis. The logistic regression revealed that metachronous CLM (OR = 2.781; p = 0.002), the use of an epidermal growth factor receptor inhibitor (OR = 3.891; p = 0.001), and radiological response (OR = 3.219; p = 0.001) were associated with higher infiltration of these cells. Conclusions High frequencies of NK and T cells in response to chemotherapy predict OS in CLM patients. These findings provide important insights that can help physicians to choose the best treatment option and adopt more predictive follow-up strategies for patients with CLM.
引用
收藏
页码:1226 / 1236
页数:11
相关论文
共 40 条
  • [1] The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
    Adam, Rene
    De Gramont, Aimery
    Figueras, Joan
    Guthrie, Ashley
    Kokudo, Norihiro
    Kunstlinger, Francis
    Loyer, Evelyne
    Poston, Graeme
    Rougier, Philippe
    Rubbia-Brandt, Laura
    Sobrero, Alberto
    Tabernero, Josep
    Teh, Catherine
    Van Cutsem, Eric
    [J]. ONCOLOGIST, 2012, 17 (10) : 1225 - 1239
  • [2] VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
    Arjaans, Marlous
    Schroder, Carolina P.
    Oosting, Sjoukje F.
    Dafni, Urania
    Kleibeuker, Josee E.
    de Vries, Elisabeth G. E.
    [J]. ONCOTARGET, 2016, 7 (16) : 21247 - 21258
  • [3] Belghiti J., 2000, HPB, V2, P333, DOI DOI 10.1016/S1365-182X(17)30755-4
  • [4] Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck
    Bier, H
    Hoffmann, T
    Haas, I
    van Lierop, A
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (03) : 167 - 173
  • [5] Cure Model Survival Analysis After Hepatic Resection for Colorectal Liver Metastases
    Cucchetti, Alessando
    Ferrero, Alessandro
    Cescon, Matteo
    Donadon, Matteo
    Russolillo, Nadia
    Ercolani, Giorgio
    Stacchini, Giacomo
    Mazzotti, Federico
    Torzilli, Guido
    Pinna, Antonio Daniele
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) : 1908 - 1914
  • [6] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    Cunningham, D
    Humblet, Y
    Siena, S
    Khayat, D
    Bleiberg, H
    Santoro, A
    Bets, D
    Mueser, M
    Harstrick, A
    Verslype, C
    Chau, I
    Van Cutsem, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) : 337 - 345
  • [7] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [8] Doherty DG, 1999, J IMMUNOL, V163, P2314
  • [9] Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
    Folprecht, G.
    Gruenberger, T.
    Bechstein, W.
    Raab, H. -R.
    Weitz, J.
    Lordick, F.
    Hartmann, J. T.
    Stoehlmacher-Williams, J.
    Lang, H.
    Trarbach, T.
    Liersch, T.
    Ockert, D.
    Jaeger, D.
    Steger, U.
    Suedhoff, T.
    Rentsch, A.
    Koehne, C. -H.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (05) : 1018 - 1025
  • [10] Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases
    Fong, Y
    Fortner, J
    Sun, RL
    Brennan, MF
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 1999, 230 (03) : 309 - 318